Demo switcher — each of the twelve seeded patients exercises a different product path.
Six years on the same two blood-pressure medications, refills like clockwork, home cuff readings in range. The flagship green: from tap to renewed in under two minutes, because nothing about him needs a visit.
Three years stable on sertraline with current, low PHQ-2 scores. Her renewal is a structured check-in and a signature — not a half-day off work.
Everything about Harold is stable except one thing: his lipid panel is 14 months old. Demonstrates approve-with-lab-order — a 30-day bridge supply, a lab order to a draw site near him, automatic re-queue when the result lands.
Five years on the same levothyroxine dose, TSH of 1.8 three months ago. The pure lab-gate condition running green — there was never a clinical reason for her annual-visit requirement.
Refilling his rescue inhaler every three weeks while stretching his controller — a real clinical signal most refill lines would never see. The system catches it and routes him to a short visit instead of rubber-stamping.
A1c of 6.8 four months ago, weight trending down, refills on time. Her semaglutide renewal used to mean a co-pay and an afternoon; now it's a check-in.
His losartan dose was increased ten weeks ago, so the dose-stability factor holds that one renewal at yellow until the three-month mark — and the timeline shows him the exact date he turns green. His metformin renews green today.
Recently moved to South Dakota; his history is scattered across a Minnesota health system, a hospital network, and a pharmacy chain. The ingestion showcase: watch three provenance-tagged sources merge in his chart, and his tier move from yellow to green the moment his labs arrive.
A five-month refill gap last year during an insurance lapse, re-stabilized since. Adherence scoring with context: the gap is flagged, the reason is captured, and a clinician who can see the whole story renews her.
Eighteen months on tirzepatide with a steady downward weight trend and near-perfect refills. He escaped prior-auth churn once already; StableCare makes sure scheduling never interrupts what's working.
Her ingested ophthalmology record surfaced timolol eye drops — systemically absorbed, and additive with her amlodipine in a 74-year-old. The interaction gate routes her TO care with the reason stated. This is the credibility case: the system that renews fast is the same system that stops when it shouldn't renew.
Fourteen months stable on bupropion — but his records only document eight, and his prior prescriber can't be identified. Record completeness holds him at yellow, and the resolution is a records request, not a visit.